Using data from automated dispensing units to identify adverse drug reactions

American Journal of Health-System Pharmacy

Volumn 62, Issue 22, 2005, Pages 2397-2400

  McIntosh, Shadreka T ^a,b   Petropoulos, Jerilyn B ^c  

^a CVS PatientCARE Network   (United States)

^b FLORIDA A AND M UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BENZATROPINE; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; DANTROLENE; DIAGNOSTIC AGENT; DIAZEPAM; DIGOXIN; DIGOXIN ANTIBODY F(AB) FRAGMENT; DIPHENHYDRAMINE; DRUG; FLUMAZENIL; GLUCAGON; GLUCOSE; HEPARIN; HORMONE; INFUSION FLUID; INSULIN; METHYLPREDNISOLONE; NALOXONE; NARCOTIC AGENT; OPIATE; PHYTOMENADIONE; POLYSTYRENE; PREDNISONE; PROTAMINE; WARFARIN;

ARTICLE; AUTOMATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG OVERDOSE; DRUG SURVEILLANCE PROGRAM; EXTRAPYRAMIDAL SYMPTOM; FOOD AND DRUG ADMINISTRATION; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HYPERKALEMIA; HYPOGLYCEMIA; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERNATIONAL NORMALIZED RATIO; LENGTH OF STAY; NEUROLEPTIC MALIGNANT SYNDROME; PHARMACIST; PHARMACY; PILOT STUDY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; SIDE EFFECT; SYMPTOMATOLOGY;

EID: 28244475917     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp040576     Document Type: Article

References (10)

1. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Health-Syst Pharm. 1995; 52:417-9.
2. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002; 36:1331-6.
3. Troutman WG, Doherty KM. Comparison of voluntary adverse drug reaction reports and corresponding medical records. Am J Health-Syst Pharm. 2003; 60:572-5.
4. Cox AR, Anton C, Goh CH et al. Adverse drug reactions in patients admitted to hospital identified by discharge ICD-10 codes and by spontaneous reports. Br J Clin Pharmacol. 2001; 52:337-9.
5. Kanjanarat P, Winterstein AG, Johns TE et al. Nature of preventable adverse drug events in hospitals: a literature review. Am J Health-Syst Pharm. 2003; 60:1750-9.
6. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992; 27:538.
7. Senst BL, Achusim LE, Genest RP et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health-Syst Pharm. 2001; 58:1126-32.
8. Brewer T, Colditz GA. Postmarketing surveillance and adverse drug reactions: current perspectives and future needs. JAMA. 1999; 281:824-9.
9. Leape LL. Reporting of adverse events. N Engl J Med. 2002; 347:1633-8.
10. Romero AV, Malone DC. Accuracy of adverse-drug-event reports collected using an automated dispensing system. Am J Health-Syst Pharm. 2005; 62:1375-80.